SCHEMBL8316075

SCHEMBL8316075

CCCCS(=O)(=O)OC(=O)CCN

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.37
CES2 O00748 5/20 0.37
CES1 P23141 5/20 0.37
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
THRB P10828 1/20 0.36
CNR1 P21554 1/20 0.36
CA12 O43570 2/20 0.35
CA14 Q9ULX7 2/20 0.35
HTR2C P28335 1/20 0.34
TLR2 O60603 2/20 0.33
CA2 P00918 2/20 0.33
DGKA P23743 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
LMNA P02545 3/20 0.32
CA1 P00915 1/20 0.31
NPC1 O15118 1/20 0.31
S1PR2 O95136 1/20 0.31
S1PR4 O95977 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6578152 0.93 CES2 (0.41) CES2CES1ALDH1A1MAPTTHRB
SCHEMBL22717119 0.84 DGKA (0.44) CYP1A2CES2CES1ALDH1A1MAPT
SCHEMBL32679584 0.82 CES2 (0.44) CES2CES1CA12CA14CA2
SCHEMBL17085777 0.82 DGKA (0.47) CES2CES1ALDH1A1MAPTTHRB
SCHEMBL29606730 0.82 DGKA (0.43) CYP1A2CES2CES1ALDH1A1MAPT
SCHEMBL3634120 0.82 DGKA (0.47) CES2CES1ALDH1A1MAPTTHRB
SCHEMBL5156066 0.82 DGKA (0.47) CES2CES1ALDH1A1MAPTTHRB
SCHEMBL31051576 0.82 DGKA (0.47) CES2CES1ALDH1A1MAPTTHRB
SCHEMBL15874693 0.82 DGKA (0.47) CES2CES1ALDH1A1MAPTTHRB
SCHEMBL5393249 0.82 DGKA (0.47) CES2CES1ALDH1A1MAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0944619-A1 NOVEL INTEGRIN RECEPTOR ANTAGONISTS Du Pont Pharmaceuticals Company (US) 1999-09-29 EP claimed
WO-1998023608-A1 NOVEL INTEGRIN RECEPTOR ANTAGONISTS DUPONT PHARMACEUTICALS COMPANY (US) 1998-06-04 WO claimed